UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
SCHEDULE 13G
Under the Securities Exchange Act of 1934
(Amendment No. 4)*
------
PLC Systems Inc.
----------------------------------------------------
(Name of Issuer)
Common Stock
----------------------------------------------------
(Title of Class of Securities)
69341D 10 4
----------------------------------------------------
(CUSIP Number)
Check the following box if a fee is being paid with this statement [ ]. (A fee
is not required only if the filing person: (1) has a previous statement on file
reporting beneficial ownership of more than five percent of the class of
securities described in Item 1; and (2) has filed no amendment subsequent
thereto reporting beneficial ownership of five percent or less of such class.)
(See Rule 13d-7.)
*The remainder of this cover page shall be filled out for a reporting person's
initial filing on this form with respect to the subject class of securities, and
for any subsequent amendment containing information which would alter the
disclosures provided in a prior page.
The information required in the remainder of this cover page shall not be deemed
to be "filed" for the purpose of Section 18 of the Securities Exchange Act of
1934 ("Act") or otherwise subject to the liabilities of that section of the Act
but shall be subject to all other provisions of the Act (however, see the
Notes).
Page 2 of 7
CUSIP No. 69341D 10 4 13G
- --------------------------------------------------------------------------------
(1) Names of Reporting Persons.
S.S. or I.R.S. Identification No. of Above Person
Robert I. Rudko, Ph.D.
- --------------------------------------------------------------------------------
(2) Check the Appropriate Box if a Member of a Group (a) [ ]
(b) [ ]
- --------------------------------------------------------------------------------
(3) SEC Use Only
- --------------------------------------------------------------------------------
(4) Citizenship or Place of Organization
United States
- --------------------------------------------------------------------------------
Number of Shares (5) Sole Voting Power
1,174,251 (includes 139,567 shares
underlying options exercisable within
the next sixty (60) days).
Beneficially --------------------------------------------
(6) Shared Voting Power
Owned by -0-
--------------------------------------------
Each Reporting (7) Sole Dispositive Power
1,174,251 (includes 139,567 shares
underlying options exercisable within
the next sixty (60) days).
Person With --------------------------------------------
(8) Shared Dispositive Power
-0-
- --------------------------------------------------------------------------------
(9) Aggregate Amount Beneficially Owned by Each Reporting Person
1,174,251 (includes 139,567 shares underlying options exercisable within
the next sixty (60) days).
-------------------------------------------------------------------------------
(10) Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares*
This amount excludes 94,762 shares owned by Nancy Rudko, Dr. Rudko's
wife. Dr. Rudko disclaims beneficial ownership of all shares held by his
wife. This amount also excludes 200,000 shares from an option to purchase
up to 300,000 shares of Common Stock through December 31, 1999, at a
price of $4.00 per share, which option vests on December 31, 1999 or upon
receipt of pre-market approval ("PMA") of the Company's patented laser
system known as THE HEART LASER(TM)(the "Heart Laser"), except that all
such options shall vest immediately in the event of a sale or acquisition
of all or substantially all of the assets of the
Page 3 of 7
Company or the sale of all or substantially all of the Company's stock to
an acquiring party.
This amount also excludes 14,000 shares held by Dr. Rudko's adult
children, as to which shares he disclaims any beneficial interest.
- --------------------------------------------------------------------------------
(11) Percent of Class Represented by Amount in Row (9)
7.2%
- --------------------------------------------------------------------------------
(12) Type of Reporting Person (See Instructions)
IN
- --------------------------------------------------------------------------------
Item 1(a). NAME OF ISSUER:
PLC Systems Inc.
Item 1(b). ADDRESS OF ISSUER'S PRINCIPAL EXECUTIVE OFFICES:
10 Forge Park, Franklin, Massachusetts 02038
Item 2(a). NAME OF PERSON FILING:
Robert I. Rudko, Ph.D.
Item 2(b). ADDRESS OF PRINCIPAL BUSINESS OFFICE:
10 Forge Park, Franklin, Massachusetts 02038
Item 2(c). CITIZENSHIP:
United States
Item 2(d). TITLE OF CLASS OF SECURITIES:
Common Stock
Item 2(e). CUSIP NUMBER:
69431D 10 4
Page 4 of 7
Item 3. IF THIS STATEMENT IS FILED PURSUANT TO RULES 13d-1(b), OR
13d-2(b), CHECK WHETHER THE PERSON FILING IS A:
(a) [ ]Broker or Dealer registered under section 15 of the Act
(b) [ ] Bank as defined in section 3(a) (6) of the Act
(c) [ ] Insurance Company as defined in section 3(a) (19) of
the Act
(d) [ ] Investment Company registered under section 8 of the
Investment Company Act
(e) [ ] Investment Adviser registered under section 203 of the
Investment Advisers
Act of 1940
(f) [ ] Employee Benefit Plan, Pension Fund which is
subject to the provisions of the Employee Retirement
Income Security Act of 1974 or Endowment Fund
(g) [ ] Parent Holding Company,in accordance with ss.240.13d-1
(b) (ii) (G)
(h) [ ] Group, in accordance with ss.240.13d-1 (b) (1) (ii)(H)
Item 4. OWNERSHIP.
(a) AMOUNT BENEFICIALLY OWNED AS OF DECEMBER 31, 1996:
1,174,251 shares of Common Stock. This amount
includes 139,567 shares of Common Stock underlying
options that are exercisable within sixty (60) days
of the date hereof. This amount excludes 94,762
shares owned by Nancy Rudko, Dr. Rudko's wife. Dr.
Rudko disclaims beneficial ownership of all shares
held by his wife. This amount also excludes 200,000
shares from an option to purchase up to 300,000
shares of Common Stock through December 31, 1999 at a
price of $4.00 per share, which options vest at
December 31, 1999 or earlier upon receipt of
pre-market approval ("PMA") of the Company's patented
laser system known as THE HEART LASER(TM) (the "Heart
Laser"), except that all such options shall vest
immediately in the event of a sale or acquisition of
all or substantially all of the assets of the Company
or the sale of all or substantially all of the
Company's stock to an acquiring party. This amount
also excludes 14,000 shares held by Dr. Rudko's adult
children, as to which shares he disclaims any
beneficial interest.
Page 5 of 7
(b) PERCENT OF CLASS:
7.2%
(c) NUMBER OF SHARES AS TO WHICH SUCH PERSON HAS:
(i) Sole power to vote or to direct the vote:
1,174,251 shares of Common Stock. This amount
includes 139,567 shares of Common Stock
underlying options that are exercisable within
sixty (60) days of the date hereof. This amount
excludes 94,762 shares owned by Nancy Rudko, Dr.
Rudko's wife. Dr. Rudko disclaims beneficial
ownership of all shares held by his wife. This
amount also excludes 200,000 shares from an
option to purchase up to 300,000 shares of
Common Stock through December 31, 1999 at a
price of $4.00 per share, which options vest at
December 31, 1999 or earlier upon receipt of
pre-market approval ("PMA") of the Company's
patented laser system known as THE HEART
LASER(TM)(the "Heart Laser"), except that all
such options shall vest immediately in the event
of a sale or acquisition of all or substantially
all of the assets of the Company or the sale of
all or substantially all of the Company's stock
to an acquiring party. This amount also excludes
14,000 shares held by Dr. Rudko's adult
children, as to which shares he disclaims any
beneficial interest.
(ii) Shared power to vote or to direct the vote: 0
shares.
(iii) Sole power to dispose or to direct the
disposition of: 1,174,251 shares of Common
Stock. This amount includes 139,567 shares of
Common Stock underlying options that are
exercisable within sixty (60) days of the date
hereof. This amount excludes 94,762 shares owned
by Nancy Rudko, Dr. Rudko's wife. Dr. Rudko
disclaims beneficial ownership of all shares
held by his wife. This amount also excludes
200,000 shares from an option to purchase up to
300,000 shares of Common Stock through December
31, 1999 at a price of $4.00 per share, which
options vest at December 31, 1999 or earlier
upon receipt of pre-market approval ("PMA") of
the Company's patented laser system known as THE
HEART LASER(TM)(the "Heart Laser"), except that
all such options shall vest immediately in the
event of a sale or acquisition of all or
substantially all of the assets of the Company
or the sale of all or substantially all of the
Company's stock to an acquiring party. This
amount also excludes 14,000 shares held by Dr.
Rudko's adult children, as to which shares he
disclaims any beneficial interest.
Page 6 of 7
(iv) Shared power to dispose or to direct the
disposition of: 0 shares.
Item 5. OWNERSHIP OF FIVE PERCENT OR LESS OF A CLASS.
If this statement is being filed to report the fact that as of the date
hereof the reporting person has ceased to be the beneficial owner of more than
five percent of the class of securities, check the following. [ ]
Item 6. OWNERSHIP OF MORE THAN FIVE PERCENT ON BEHALF OF
ANOTHER PERSON.
Not applicable.
Item 7. IDENTIFICATION AND CLASSIFICATION OF THE SUBSIDIARY WHICH
ACQUIRED THE SECURITY BEING REPORTED ON BY THE PARENT
HOLDING COMPANY.
Not applicable.
Item 8. IDENTIFICATION AND CLASSIFICATION OF MEMBERS OF THE
GROUP.
Not applicable.
Item 9. NOTICE OF DISSOLUTION OF GROUP.
Not applicable.
Page 7 of 7
Item 10. CERTIFICATION.
By signing below I certify that, to the best of my knowledge
and belief, the securities referred to above were acquired in
the ordinary course of business and were not acquired for the
purpose of and do not have the effect of changing or
influencing the control of the issuer of such securities and
were not acquired in connection with or as a participant in
any transaction having such purposes or effect.
SIGNATURE
After reasonable inquiry and to the best of its or his knowledge and
belief, each of the undersigned certifies that the information set forth in this
statement is true, complete and correct.
February 12, 1997
---------------------------------------------
(Date)
/s/ Robert I. Rudko, Ph.D.
---------------------------------------------
(Signature)
Robert I. Rudko, Ph.D., Chairman of the Board
---------------------------------------------
(Name and Title)
